In 2025, Imagine for Margo is funding 9 innovative research projects, selected by the SFCE, on childhood cancer
In 2025, Imagine for Margo is funding 9 innovative research projects, selected by the SFCE, on childhood cancer
On March 20 and 21, the French Society for the Fight Against Childhood and Adolescent Cancers and Leukemias (SFCE) held its first annual 2025 symposium in Paris. Over two days, numerous doctors and researchers presented their latest work. Among the notable advances, the conference highlighted new radiotherapy approaches to eradicate metastases, particularly intracerebral ones, discoveries […]
What is a nephroblastoma?
What is a nephroblastoma?
Nephroblastoma, also known as Wilms’ tumor, is the most common kidney cancer in children. It accounts for between 5% and 14% of all childhood cancers (1 case per 10,000 births, with nearly a hundred cases per year on average in France). Wilms’ tumor usually appears in children under 5 years old, but it can sometimes […]
What is a rhabdomyosarcoma?
What is a rhabdomyosarcoma?
Rhabdomyosarcoma (RMS) is the most common soft tissue cancer (approximately 60%) in children and adolescents (5% of all pediatric solid tumors). However, it remains a rare cancer with about a hundred cases recorded in France per year. It occurs at all ages with a peak incidence between 2 and 5 years. RMS develops from skeletal […]
Role of Calcium Conductances in the Development of Pediatric Sarcomas
Role of Calcium Conductances in the Development of Pediatric Sarcomas
Childhood Sarcomas After blood cancers and brain tumors, sarcomas are the most common pediatric tumors. Among these, we distinguish soft tissue sarcomas including rhabdomyosarcomas (RMS, the most common) and bone sarcomas including Ewing sarcomas (ES, the second most common after osteosarcomas). In pediatrics, sarcomas develop at any age and in any part of the body, […]
Targeting DNA Repair in H3.3 Mutant High-Grade Pediatric Gliomas
Targeting DNA Repair in H3.3 Mutant High-Grade Pediatric Gliomas
High-Grade Gliomas in Children High-grade gliomas are the most common malignant tumors in children and adolescents. Our understanding of these cancers, particularly gained during the BIOMEDE trial led by Dr. Jacques Grill, has led to better defining and understanding these diseases. Now that we know that malignant gliomas in children and adults are not alike, […]
Assessment of the Toxicity of Intravitreal Carboplatin Injections in the Treatment of Retinoblastoma
Assessment of the Toxicity of Intravitreal Carboplatin Injections in the Treatment of Retinoblastoma
Childhood Retinoblastomas Retinoblastoma is a malignant tumor that develops in the retina, the layer of light-sensitive tissue at the back of the eye. This tumor arises from immature retinal cells called “developing retinal cells.” Retinoblastoma is a cancer that mainly affects young children, typically before the age of 5 (95% of cases). Estimates suggest that […]
Targeting Pediatric Brain Tumors with O-Acetyl-GD2-specific CAR T Lymphocytes
Targeting Pediatric Brain Tumors with O-Acetyl-GD2-specific CAR T Lymphocytes
Childhood Brain Cancers Brain tumors are the most common solid tumors in children. The annual estimated number of new cases is about 30 per million for all childhood brain tumors. Gliomas encompass tumors of the central nervous system, which differ based on the brain’s original cell types (astrocytes or oligodendrocytes or both) and their aggressiveness […]
Study of Predisposition to Therapeutic Resistance in Osteosarcomas
Study of Predisposition to Therapeutic Resistance in Osteosarcomas
Background of the Project Osteosarcoma is the most common primary bone tumor affecting children and young adults (incidence peak between 15 and 19 years old). The current treatment for this cancer involves tumor removal, combined with polychemotherapy. Unfortunately, a lack of response to antitumor drugs is often observed, promoting the development of metastases and leading […]
